Pacific Palisades, California, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not…
Los Angeles, California, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and isn't medical…
RICHMOND, Ind., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Liberation Bioindustries announces its co-founders have assumed new roles in the company;…
Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presenceNext-generation BTK protein degrader APG-3288 receives…
NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), today announced…
Lommel / Hamburg, 01/15/2026 – Aqua free, a leading provider of innovative drinking-water hygiene solutions, has successfully moved into its new,…
January 14, 2026 01:30 ET | Source: Orion Oyj ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 14 JANUARY 2026 at…
14 abstracts will be presented across a range of neurological conditions including post‑stroke spasticity, cervical dystonia, blepharospasm and other movement…
— First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET…
Not intended for US and UK audiences BI 765423 has been developed to target IL-11, a key driver of fibrosis…